T. Peter Kingham, MD, FACS

T. Peter Kingham, MD, FACS

T. Peter Kingham, MD, FACS

Profile:

Dr. Kingham is an Associate Attending Surgeon in the Hepatopancreatobiliary Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center. Dr. Kingham directs exciting clinical trials examining methods for quickly determining the stage of pancreatic cancer, identifying genetic signatures of colorectal cancer to create genetic scoring systems, and using an image-guided 3-dimensional liver modeling system to improve outcomes of liver surgery. He has also written multiple book chapters and many papers on topics related to treating tumors of the liver, bile ducts, gallbladder, and pancreas, and given lectures internationally.

Dr. Kingham is also the Director of Global Cancer Disparity Initiatives at MSK. Over the past 15 years, he has spent time in developing countries — Tanzania, Sierra Leone, South Africa, Mexico, Malawi, and Nigeria — providing surgery and cancer care, and also training local medical professionals. These experiences led him, in 2007, to co-found Surgeons OverSeas (SOS), a non-profit organization for which he now serves as president. In 2015, he was appointed Director of Global Cancer Disparity Initiatives at MSK where he has created a consortium of hospitals in West Africa that allows MSK physicians to collaborate with physicians working in low-income countries. These efforts have led to several prospective studies that will determine how to diagnose patients with cancer in low resource environments and determine why some cancers seem to behave differently in West African patients when compared with the same cancers in US patients.


Meet Dr. Kingham:


Publications:

  1. Narayan, RR, Goldman, DA, Gonen, M, Reichel, J, Huberman, KH, Raj, S et al.. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. Ann. Surg. Oncol. 2019; :. doi: 10.1245/s10434-019-07201-5. PubMed PMID:30706231 .
  2. Pak, LM, Gagnière, J, Allen, PJ, Balachandran, VP, D'Angelica, MI, DeMatteo, RP et al.. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases. J. Gastrointest. Surg. 2019; :. doi: 10.1007/s11605-019-04106-2. PubMed PMID:30680630 .
  3. Lawrence, SA, McIntyre, CA, Pulvirenti, A, Seier, K, Chou, Y, Gonen, M et al.. Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study. J. Am. Coll. Surg. 2019; :. doi: 10.1016/j.jamcollsurg.2018.12.018. PubMed PMID:30630087 .
  4. Olasehinde, O, Alatise, OI, Arowolo, OA, Mango, VL, Olajide, OS, Omisore, AD et al.. Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities. Eur J Cancer Care (Engl). 2019; :e12986. doi: 10.1111/ecc.12986. PubMed PMID:30614109 .
  5. Narayan, RR, Creasy, JM, Goldman, DA, Gönen, M, Kandoth, C, Kundra, R et al.. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations. Cancer. 2019;125 (4):575-585. doi: 10.1002/cncr.31850. PubMed PMID:30427539 .
  6. Cohen, NA, Kingham, TP. Minimally Invasive Staging Surgery for Cancer. Surg. Oncol. Clin. N. Am. 2019;28 (1):61-77. doi: 10.1016/j.soc.2018.07.006. PubMed PMID:30414682 .
  7. Kunstman, JW, Goldman, DA, Gönen, M, Balachandran, VP, D'Angelica, MI, Kingham, TP et al.. Outcomes after Pancreatectomy with Routine Pasireotide Use. J. Am. Coll. Surg. 2019;228 (2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. PubMed PMID:30414453 .
  8. Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP et al.. Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients. World J Surg. 2019;43 (2):395. doi: 10.1007/s00268-018-4845-x. PubMed PMID:30406321 .
  9. Harding, JJ, Nandakumar, S, Armenia, J, Khalil, DN, Albano, M, Ly, M et al.. Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies. Clin. Cancer Res. 2018; :. doi: 10.1158/1078-0432.CCR-18-2293. PubMed PMID:30373752 .
  10. Nota, CL, Woo, Y, Raoof, M, Boerner, T, Molenaar, IQ, Choi, GH et al.. Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study. Ann. Surg. Oncol. 2019;26 (2):583-590. doi: 10.1245/s10434-018-6928-1. PubMed PMID:30334196 .
  11. Al Efishat, M, Attiyeh, MA, Eaton, AA, Gönen, M, Covey, AM, D'Angelica, MI et al.. Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection. HPB (Oxford). 2018; :. doi: 10.1016/j.hpb.2018.08.010. PubMed PMID:30293867 .
  12. Gaspersz, MP, Buettner, S, Roos, E, van Vugt, JLA, Coelen, RJS, Vugts, J et al.. A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma. J Surg Oncol. 2018;118 (3):469-476. doi: 10.1002/jso.25174. PubMed PMID:30132904 .
  13. Attiyeh, MA, Chakraborty, J, Gazit, L, Langdon-Embry, L, Gonen, M, Balachandran, VP et al.. Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis. HPB (Oxford). 2018; :. doi: 10.1016/j.hpb.2018.07.016. PubMed PMID:30097414 PubMed Central PMC6367060.
  14. Gyedu, A, Gaskill, CE, Agbedinu, K, Salazar, DR, Kingham, TP. Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes. J Surg Oncol. 2018;118 (3):581-587. doi: 10.1002/jso.25168. PubMed PMID:30095201 PubMed Central PMC6160332.
  15. Zheng, J, Sadot, E, Vigidal, JA, Klimstra, DS, Balachandran, VP, Kingham, TP et al.. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS ONE. 2018;13 (7):e0200776. doi: 10.1371/journal.pone.0200776. PubMed PMID:30052636 PubMed Central PMC6063411.
  16. Gagnière, J, Dupré, A, Gholami, SS, Pezet, D, Boerner, T, Gönen, M et al.. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. Ann. Surg. 2018; :. doi: 10.1097/SLA.0000000000002968. PubMed PMID:29995686 .
  17. Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP et al.. Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients. World J Surg. 2019;43 (2):385-394. doi: 10.1007/s00268-018-4726-3. PubMed PMID:29955938 PubMed Central PMC6310662.
  18. Creasy, JM, Midya, A, Chakraborty, J, Adams, LB, Gomes, C, Gonen, M et al.. Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases. Eur Radiol. 2018; :. doi: 10.1007/s00330-018-5542-8. PubMed PMID:29922934 PubMed Central PMC6301122.
  19. Margonis, GA, Sasaki, K, Gholami, S, Kim, Y, Andreatos, N, Rezaee, N et al.. Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. Br J Surg. 2018;105 (9):1210-1220. doi: 10.1002/bjs.10838. PubMed PMID:29691844 .
  20. Alatise, OI, Ayandipo, OO, Adeyeye, A, Seier, K, Komolafe, AO, Bojuwoye, MO et al.. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer. Cancer. 2018;124 (13):2766-2773. doi: 10.1002/cncr.31399. PubMed PMID:29645077 PubMed Central PMC6005740.
Search PubMed